Dagnon Terry 4
4 · Outlook Therapeutics, Inc. · Filed Feb 17, 2021
Insider Transaction Report
Form 4
Dagnon Terry
Chief Operating Officer
Transactions
- Sale
Common Stock
2021-02-12$2.55/sh−63,700$162,435→ 1,143,757 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 - $2.605, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 25% of the shares as provided in that certain Consulting Agreement dated January 27, 2020.